eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank

1/2024
vol. 16
 
Share:
Share:
abstract:
Original paper

Brachytherapy in gynecological malignancies at a tertiary care hospital: An analysis

Rasla Parween
1
,
Aruna R
1
,
Chendil V
1
,
Mahita Reddy
1
,
Ramyaa S
1
,
Varun Chandra
1
,
Yuvaraj U
1
,
Amrut S Kadam
1

  1. Department of Radiation Oncology, Victoria Hospital, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India
J Contemp Brachytherapy 2024; 16, 1: 67–71
Online publish date: 2024/02/27
View full text Get citation
 
Purpose:
Brachytherapy plays a crucial role in the standard of care for locally advanced gynecological malignancies. In this report, we present the experience from a tertiary teaching hospital, which is a referral center for image-guided brachytherapy (IGBT) in the management of locally advanced gynecological malignancies.

Material and methods:
This was a retrospective study of 130 patients referred to our hospital for IGBT after receiving initial external beam radiotherapy in their primary healthcare facilities, from January 2021 till January 2023. CT-based planning was done to delineate high-risk clinical target volume (HR-CTV). Dose of 6-7.5 Gy in 3-4 fractions was prescribed. Overall treatment time (OTT) was calculated, and patients were assessed for clinical response and toxicity after three months.

Results:
All patients received IGBT using an intra-cavitary or interstitial technique. The D90 HR-CTV mean EQD2 dose was 28.34 ±2.78 Gy. The mean EQD2 dose to 2 cc of the bladder, rectum, and sigmoid was 18.31 ±5.19 Gy, 14.14 ±5.76 Gy, and 17.43 ±4.75 Gy, respectively. The median interval time between the last fraction of external beam radiation therapy (EBRT) and first evaluation in the hospital was 19 (range, 13-28) days (interquartile range [IQR]). The median time between the completion of chemoradiation and brachytherapy procedure was 25 (range, 19-33) days (IQR). The mean overall treatment time (OTT) was 63.5 ±14.7 days.

Conclusions:
This study highlights the established advantages of image-guided interstitial brachytherapy and associated challenges. To optimize the overall treatment duration, it is imperative to prioritize and update the referral processes for brachytherapy centers.

keywords:

brachytherapy, ISBT, HDR, gynecological cancer

 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.